The induction of cyclooxygenase-1 by a tobacco carcinogen inU937 human macrophages is correlated to the activation of NF-κB

Carcinogenesis

Volumn 21, Issue 9, 2000, Pages 1745-1751

  Rioux, N ^a   Castonguay, A ^a  

^a UNIVERSITÉ LAVAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

1 [3 [5 (4 FLUOROPHENOXY) 2 FURYL] 1 METHYL 2 PROPYNYL] 1 HYDROXYUREA; 4 (METHYLNITROSAMINO) 1 (3 PYRIDYL) 1 BUTANONE; ACETYLCYSTEINE; ACETYLSALICYLIC ACID; ACRYLIC ACID DERIVATIVE; ACTIN; CAPSAICIN; CARCINOGEN; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; IMMUNOGLOBULIN KAPPA CHAIN; LIPOPOLYSACCHARIDE; N (2 CYCLOHEXYLOXY 4 NITROPHENYL)METHANESULFONAMIDE; NICOTINE; NONSTEROID ANTIINFLAMMATORY AGENT; PHORBOL 13 ACETATE 12 MYRISTATE; PROADIFEN; PROSTAGLANDIN D2; PROSTAGLANDIN E2; PROSTAGLANDIN F1 ALPHA; PROSTAGLANDIN F2 ALPHA; PYRROLIDINE DITHIOCARBAMATE; REACTIVE OXYGEN METABOLITE; TEPOXALIN; THROMBOXANE B2; TOBACCO SMOKE;

ARTICLE; CANCER PREVENTION; CELL STRAIN U937; CHEMOPROPHYLAXIS; CONTROLLED STUDY; DRUG ACTIVITY; ENZYME ACTIVITY; ENZYME INDUCTION; ENZYME INHIBITION; HUMAN; HUMAN CELL; LUNG CANCER; LUNG CARCINOGENESIS; MACROPHAGE; MUTAGENICITY; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; SMOKING;

EID: 0033851468     PISSN: 01433334     EISSN: None     Source Type: Journal    
DOI: 10.1093/carcin/21.9.1745     Document Type: Article

References (48)

1. The biological significance of tobacco-specific N-nitrosamines: Smoking and adenocarcinoma of the lung
2. Activation of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) in human lung microsomes by cytochromes P450, lipoxygenase and hydroperoxides
3. Metabolic activation and detoxification of tobacco-specific nitrosamines-a model for cancer prevention strategies
4. Prevention of NNK-induced lung tumorigenesis in A/J mice by acetylsalicylic acid and NS-398
5. Effects of NSAIDs on NNK-induced pulmonary and gastric tumorigenesis in A/J mice
6. Inhibition of prostaglandin synthesis by a mechanism of action for aspirin-like drugs
7. Prostaglandin synthase 2
8. Increased expression of cyclooxygenase 2 occurs frequently in human lung cancers, specifically in adenocarcinomas
9. Genoprotection by UDP-glucuronosyltransferases in peroxidase-dependant, reactive oxygen species-mediated micronucleus initiation by the carcinogens 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone and benzo[a]pyrene
10. Characterization of the human gene (PTGS2) encoding prostaglandin-endoperoxidase synthase-2
11. Antioxidant and redox regulation of gene transcription
12. Establishment and characterization of a human histiocylic lymphoma cell line
13. Aberrant expression of T cell and B cell markers in myelocyte/monocyte/histiocyte-derived lymphoma and leukemia cells. Is the infrequent expression of T/B cell markers sufficient to establish a Reed-Stenberg cells?
14. Proinflammatory cytokines regulate cyclooxygenase-2 mRNA expression in human macrophages
15. Metabolism in the F344 rat of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone, a tobacco-specific carcinogen
16. Effects of pregnancy and ethanol treatment on the metabolism of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone by hamster liver and lung microsomes
17. Cleavage of structural proteins during the assembly of the head of bacteriophage T4
18. Modulation of DNA repair by various inhibitors of DNA synthesis following 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) induced DNA damage
19. Recovery from 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induce immunosuppression in A/J mice by treatment with nonsteroidal anti-inflammatory drugs
20. On the inhibition of microsomal drug metabolism by SKF 525-A
21. NS-398, a new anti-inflammatory agent, that selectively inhibits prostaglandin G/H synthase/cyclooxygenase (COX-2) activity in vitro
22. Optimization of the potency and duration of action of N-hydroxyurea 5-lipoxygenase inhibitors
23. Tepoxalin: A dual cyclooxygenase/5-lipoxygenase inhibitor of arachidonic acid metabolism with potent anti-inflammatory activity and a favorable gastrointestinal profile
24. Suppression of NF-kappaB activation and NF-kappaB-dependant gene expression by tepoxalin, a dual inhibitor of cyclooxygenase and 5-lipoxygenase
25. Caffeic acid phenethyl ester is a potent and specific inhibitor of activation of nuclear transcription factor NF-kappaB
26. Capsaicin (8-methyl-N-vanillyl-6-nonenamide) is a potent inhibitor of nuclear transcription factor-kappa B activation by diverse agents
27. The NF-kappa B and I kappa B proteins: New discoveries and insights
28. I Kappa B proteins: Structure, function and regulation
29. Biochemistry, biology and carcinogenicity of tobacco-specific N-nitrosamines
30. Inhibitors of lipoxygenase: A new class of cancer chemopreventive agents
31. Tumor-induced immune dysfunction: The macrophage connection
32. Prostaglandin G/H synthase-2 is constitutive and dominant isoform in cultured human lung epithelial cells
33. Inhibitory effects of nonsteroidal anti-inflammatory drugs (NSAIDs) on the metabolism of 4-(methylnitrosamino)-1-(3-pyridyl)-1butanone (NNK) in mouse lung explants
34. Biotransformation of the tobacco-specific carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) in freshly isolated human lung cells
35. Prostaglandin and thromboxane biosynthesis
36. Expression of cyclooxygenase-1 and cyclooxygenase-2 in human breast cancer
37. Expression of COX-1, COX-2 and inducible nitric oxide synthase protein in human gastric antrum with Helicobacter pylori infection
38. Differentiation of monocytoid THP-1 cells with phorbol ester induces expression of prostaglandin endoperoxide synthase-1 (COX-1)
39. Reversal of the transcriptional rates of cyclooxygenase I and II genes in human fibroblasts and prostate cancer cells
40. Induction of cyclooxygenase expression and enhancement of malignant cell transformation by 2,3,7,8-tetrachlorodibennzo-p-dioxin
41. Aspirin and the potential role of prostaglandins in colon cancer
42. Increased expression of cyclooxygenase-2 in rat lung tumors induced by the tobacco-specific nitrosamine-4-(methylnitrosamino)-4-(3-pyridyl)-1-butanone: The impact of a high-fat diet
43. Cyclooxygenase-1 and -2 protein in the aberrant crypt foci of nonsteroidal anti-inflammatory drug-treated F344 rats
44. Prostaglandin endoperoxide synthase gene structure: Identification of the transcriptional start site and 5'-flanking regulatory sequences
45. 6-methylguanine
46. Mycobacterium avium complex activates nuclear factor kappaB via induction of inflammatory cytokines
47. Cooperativity between oxidants and tumor necrosis factor in the activation of nuclear factor (NF)-kappaB. Requirement of ras/mitogen-activated protein kinases in the activation of NF-kappaB by oxidants